Insider at Aileron Therapeutics (ALRN) Makes Significant Sale of Stock

Thursday, January 11, 2018 10:15 PM ET

Insider at Aileron Therapeutics (ALRN) Makes Significant Sale of Stock

A significant insider sale of the shares of Aileron Therapeutics was disclosed in a form 4 document filed with the SEC today, showing — APPLE TREE PARTNERS II LP, 10% Owner — disposed of 150,000 shares in the company having a market value of approximately $1,470,435. This is the first insider buy/sell trade in the past 90 days.

Aileron Therapeutics buy-sell trading activity is close to the 280 member peer company average. The Bio Therapeutic Drugs peer group saw 336 buy/sell trades during this period for an average of 1.2 transactions per company. However, trading at Aileron Therapeutics represents a lower number of shares per transaction. Within the peer group there were 46,351,415 shares purchased and 40,627,222 shares sold with company insiders having bought 26,258 shares on average over this time period.

Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in creating and writing this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.